AT-202 (Adept Biopharmaceutical and Technology)

N/A

Report date: 2025/06/11 10:57:52

Base Information

Drug NameAT-202 (Adept Biopharmaceutical and Technology)
Drug Alias Namebispecific NK cell-engager (Adept Biopharmaceutical and Technology)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionImmunostimulantsNatural killer cells stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAdept Biopharmaceutical and Technology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdept Biopharmaceutical and Technology Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A